Medical News

RSS

Tamiflu in short supply, pharmacists compound doses for children suffering from the H1N1 flu virus

Community pharmacists have stepped up to meet the shortage of Tamiflu by compounding doses for children suffering from the H1N1 flu virus, but they are struggling with supply problems and insurance plans, according to the National Community Pharmacists Association.

3 Nov 2009

Crohn's disease drug market driven by TNF-alpha inhibitors Humira and Remicade

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

3 Nov 2009

Cuts in cancer care a move in the wrong direction of health care reform, says COA

The Community Oncology Alliance (COA) today criticized the newest round of cuts in cancer care as a move in the wrong direction of health care reform. Although not as devastating as expected, the cuts by the Centers for Medicare and Medicaid Services (CMS) will still decrease reimbursements far beyond what the U.S. cancer care delivery system, including most patients, can bear.

3 Nov 2009

Stereotactic radiosurgery effective in eliminating Parkinson's disease tremors

Stereotactic radiosurgery (SRS) offers a less invasive way to eliminate tremors caused by Parkinson's disease and essential tremor than deep brain stimulation (DBS) and radiofrequency (RF) treatments, and is as effective, according to a long-term study presented November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

3 Nov 2009

No evidence found to link decreased physical activity and spike in obesity rates among U.S. adolescents

Decreased physical activity may have little to do with the recent spike in obesity rates among U.S. adolescents, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

3 Nov 2009

State funding declines for Phoenix Academy San Diego, seeks new sources of funding

Since 1988, Phoenix Academy San Diego has helped thousands of troubled teens reclaim their lives, establishing itself as a vital county resource for at-risk youth and their families. The Academy, a residential high school for youth with substance abuse and co-occurring mental health disorders is now suffering further declines in the state funding it relies upon to operate, it was announced today by Winnie Wechsler, Executive Director for Phoenix Houses of California.

3 Nov 2009

Efficacy trial of the world's most clinically advanced malaria vaccine candidate underway

A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania. The trial, which is expected to involve up to 16,000 children, is on schedule, with more than 5,000 children already enrolled, researchers announced Tuesday at the 5th Multilateral Initiative on Malaria Pan-African Malaria Conference.

3 Nov 2009

Lifestyle changes prevents type 2 diabetes in people at high risk for developing the disease: Study

Sustaining modest weight loss for 10 years, or taking an anti-diabetic drug over that time, can prevent or lower the incidence of type 2 diabetes in people at high risk for developing the disease, according to the Diabetes Prevention Program Outcomes Study (DPPOS), a long-term follow-up to a landmark 2001 diabetes prevention study.

3 Nov 2009

Sales of AMD LASERS' Picasso soft tissue dental lasers triple expectations

AMD LASERS, with global headquarters in Indianapolis, IN, today announced that projected sales of the Picasso soft tissue dental lasers have more than tripled expectations in the first year. The March FDA market clearance of Picasso signaled the beginning in a series of dental laser products to be developed and launched over the next few years by the locally owned and operated company.

From AMD Lasers 3 Nov 2009

Teva Pharmaceutical Industries net sales up 25%

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended September 30, 2009.

3 Nov 2009

Quintiles to deliver AstraZeneca’s clinical pharmacology studies

Quintiles today announced that it has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe.

3 Nov 2009

Affiliated Dialysis Centers to purchase nursing home dialysis business in Chicago

Affiliated Dialysis Centers, LLC (“ADC”), an independent dialysis provider based in Illinois, today announced that a definitive agreement has been reached to purchase a nursing home dialysis business in the Chicago market.

3 Nov 2009

Caliper Life Sciences to use SRU Biosystems’ label-free BIND technology for new functional assays

SRU Biosystems today announced that Caliper Life Sciences will use SRU Biosystems’ label-free BIND® technology to offer new functional assays as part of its Discovery Alliances and Services.

3 Nov 2009

Phase 1 study of STX107 for Fragile X syndrome begins

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers.

3 Nov 2009

FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today issued the following statement in response to the U.S. Food and Drug Administration (FDA) update on BYETTA® (exenatide) injection.

3 Nov 2009

Pateamine A found to inhibit yet another anti-cancer mechanism

Pateamine A (PatA), a natural product first isolated from marine sponges, has attracted considerable attention as a potential anti-cancer agent, and now a new activity has been found for it, which may reveal yet another anti-cancer mechanism. That's the assessment of Daniel Romo, a Texas A&M chemistry professor, and his colleagues at Johns Hopkins University who are pioneers in research involving this novel marine natural product.

3 Nov 2009

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.

3 Nov 2009

Baxter Healthcare wins the INFORMS Decision Analysis Society Practice Award

The Institute for Operations Research and the Management Sciences (INFORMS-) today announced that Baxter Healthcare is the winner of the INFORMS Decision Analysis Society Practice Award.

3 Nov 2009

Therapy with EBV-specific CTLs effective for severely immune-compromised patients

Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection, said a group of researchers led by those from Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital.

3 Nov 2009

Kindred Healthcare reports financial results for the third quarter of 2009

Kindred Healthcare, Inc. today announced its operating results for the third quarter ended September 30, 2009.

3 Nov 2009

Medical News

Tamiflu in short supply, pharmacists compound doses for children suffering from the H1N1 flu virus

Crohn's disease drug market driven by TNF-alpha inhibitors Humira and Remicade

Cuts in cancer care a move in the wrong direction of health care reform, says COA

Stereotactic radiosurgery effective in eliminating Parkinson's disease tremors

No evidence found to link decreased physical activity and spike in obesity rates among U.S. adolescents

State funding declines for Phoenix Academy San Diego, seeks new sources of funding

Efficacy trial of the world's most clinically advanced malaria vaccine candidate underway

Lifestyle changes prevents type 2 diabetes in people at high risk for developing the disease: Study

Sales of AMD LASERS' Picasso soft tissue dental lasers triple expectations

Teva Pharmaceutical Industries net sales up 25%

Quintiles to deliver AstraZeneca’s clinical pharmacology studies

Affiliated Dialysis Centers to purchase nursing home dialysis business in Chicago

Caliper Life Sciences to use SRU Biosystems’ label-free BIND technology for new functional assays

Phase 1 study of STX107 for Fragile X syndrome begins

FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond

Pateamine A found to inhibit yet another anti-cancer mechanism

Interim data from Schering-Plough's narlaprevir Phase IIa study

Baxter Healthcare wins the INFORMS Decision Analysis Society Practice Award

Therapy with EBV-specific CTLs effective for severely immune-compromised patients

Kindred Healthcare reports financial results for the third quarter of 2009

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News